Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

37.23 USD +0.70 (+1.92%)
Official Closing Price Updated: 5:00 PM EST, Nov 27, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Basilea reports acceptance for regulatory review of Pfizer’s marketing authorization application for antifungal isavuconazole (Cresemba®) in invasive aspergillosis in China
From GlobeNewswire News Releases
Should you invest in General Electric, Nio, Bank of America, Ford, or Pfizer?
InvestorsObserver issues critical PriceWatch Alerts for GE, NIO, BAC, F, and PFE. 
From PR Newswire
Pfizer Doses First Participant in Phase 3 Study Evaluating anti-TFPI Investigational Therapy, Marstacimab, for People With Severe Hemophilia A and B With or Without Inhibitors
Pfizer Inc. (NYSE: PFE) today announced that the first participant has been dosed in the Phase 3 BASIS study of marstacimab (PF-06741086), an anti-tissue factor pathway inhibitor (anti-TFPI) being... 
From Business Wire News Releases
Thinking about trading options or stock in Pfizer, Inovio Pharmaceuticals, Alibaba, General Electric, or Nio?
InvestorsObserver issues critical PriceWatch Alerts for PFE, INO, BABA, GE, and NIO. 
From PR Newswire
Pfizer and BioNTech to Submit Emergency Use Authorization Request Today to the U.S. FDA for COVID-19 Vaccine
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced they will submit a request today to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of their mRNA... 
From Business Wire News Releases
Pfizer and BioNTech to Submit Emergency Use Authorization Request Today to the U.S. FDA for COVID-19 Vaccine
From GlobeNewswire News Releases
Pfizer and LianBio Announce Strategic Collaboration to Expand Development of Novel Therapeutics in Greater China
Pfizer, Inc. (NYSE: PFE) and LianBio announced today that they have entered into a collaboration aimed at developing and commercializing transformative pharmaceutical products in Greater China.... 
From Business Wire News Releases
Results from Phase 3 CROWN Trial of Pfizer’s LORBRENA® (lorlatinib) in Previously Untreated ALK-Positive Lung Cancer Published in the New England Journal of Medicine
Pfizer Inc. (NYSE:PFE) today announced results from the Phase 3 CROWN trial of LORBRENA® (lorlatinib, available in Europe under the brand name LORVIQUA®) versus XALKORI® (crizotinib) in people with... 
From Business Wire News Releases
Thinking about buying stock in Pfizer, Moderna, Micro Focus, Riot Blockchain, or PG&E Corp?
InvestorsObserver issues critical PriceWatch Alerts for PFE, MRNA, MFGP, RIOT, and PCG. 
From PR Newswire
Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 Vaccine Candidate, Meeting All Primary Efficacy Endpoints
From GlobeNewswire News Releases
Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 Vaccine Candidate, Meeting All Primary Efficacy Endpoints
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that, after conducting the final efficacy analysis in their ongoing Phase 3 study, their mRNA-based COVID-19 vaccine candidate,... 
From Business Wire News Releases
Vivet Therapeutics and Pfizer Inc. Announce FDA Authorization to Proceed with GATEWAY, the Phase 1/2 Study for VTX-801, Vivet’s Investigational Gene Therapy for Wilson Disease
From GlobeNewswire News Releases
ViiV Healthcare receives FDA Breakthrough Therapy Designation for investigational, long-acting cabotegravir for HIV prevention
ViiV Healthcare receives FDA Breakthrough Therapy Designation for investigational, long-acting cabotegravir for HIV prevention 
From Business Wire News Releases
Scott+Scott Attorneys at Law LLP Investigates Pfizer, Inc.’s (PFE) Directors and Officers for Breach of Fiduciary Duties
Scott+Scott Attorneys at Law LLP Investigates Pfizer, Inc.’s (PFE) Directors and Officers for Breach of Fiduciary Duties 
From Business Wire News Releases
Thinking about buying stock in Advanced Micro Devices, Costco, Lowe's, Walgreens, or Pfizer?
InvestorsObserver issues critical PriceWatch Alerts for AMD, COST, LOW, WBA, and PFE. 
From PR Newswire
Diagnostic Testing Remains Vital as New Treatment Breakthroughs are Announced
FinancialBuzz.com News Commentary 
From PR Newswire
Thinking about buying stock in Pfizer, Moderna, Inovio Pharmaceuticals, AMC Entertainment, or HighPoint Resources?
InvestorsObserver issues critical PriceWatch Alerts for PFE, MRNA, INO, AMC, and HPR. 
From PR Newswire
Pfizer Completes Transaction to Combine Its Upjohn Business with Mylan
Pfizer Inc. (NYSE: PFE) announced today that it has completed the transaction to spin off its Upjohn Business and combine it with Mylan N.V. to form Viatris Inc. 
From Business Wire News Releases
Analysis from Phase 3 ATTR-ACT and Its Long-Term Extension Study Demonstrates VYNDAQEL® 80 mg/VYNDAMAX® 61 mg Significantly Improved Survival in Patients with Transthyretin Amyloid Cardiomyopathy (ATT
Pfizer Inc. (NYSE: PFE) announced today the publication of an analysis showing that VYNDAQEL® (tafamidis meglumine) 80 mg/VYNDAMAX® (tafamidis) 61 mg were associated with a statistically significant... 
From Business Wire News Releases
Thinking about trading options or stock in Carnival Corp, Pfizer, Bank of America, Walt Disney, or American Airlines?
InvestorsObserver issues critical PriceWatch Alerts for CCL, PFE, BAC, DIS, and AAL. 
From PR Newswire
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Angela Hwang, Group President, Biopharmaceuticals Group, at the 2nd Annual Wolfe Research... 
From Business Wire News Releases
Thinking about trading options or stock in Apple, Exxon Mobil, Pfizer, Lyft, or GameStop?
InvestorsObserver issues critical PriceWatch Alerts for AAPL, XOM, PFE, LYFT, and GME. 
From PR Newswire
Nanotechnology Based Approaches For Combating COVID-19 Could Fast-Track New Detection Modalities And Treatments
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Nanotechnology Based Approaches For Combating COVID-19 Could Fast-Track New Detection Modalities And Treatments
Financialnewsmedia.com News Commentary 
From PR Newswire
Pfizer Announces Positive Results from Fifth Phase 3 Trial of Abrocitinib, Evaluating Safety and Efficacy Across Different Dosing Regimens
Pfizer Inc. (NYSE: PFE) announced today positive top-line results from the Phase 3 JADE REGIMEN study. This 52-week study investigated abrocitinib, an investigational oral once-daily Janus kinase 1... 
From Business Wire News Releases
Pfizer and BioNTech Reach an Agreement to Supply the EU with 200 Million Doses of Their BNT162b2 mRNA-based Vaccine Candidate against COVID-19
From GlobeNewswire News Releases
Pfizer and BioNTech Reach an Agreement to Supply the EU With 200 Million Doses of Their BNT162b2 mRNA-Based Vaccine Candidate Against SARS-CoV-2
Pfizer (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that they have reached an agreement with the European Commission to supply 200 million doses of their investigational BNT162b2... 
From Business Wire News Releases
Thinking about trading options or stock in Pfizer, Apple, Anheuser Busch, Carnival Corp, or Tesla?
InvestorsObserver issues critical PriceWatch Alerts for PFE, AAPL, BUD, CCL, and TSLA. 
From PR Newswire
Transgene Presents E-Poster Outlining Detailed Results from the Phase 1b/2 Trial of TG4001 in Combination With Avelumab in Advanced HPV-Positive Cancers at SITC 2020
Regulatory News: 
From Business Wire News Releases
Thinking about buying stock in American Airlines, Carnival Corp, Pfizer, Aptevo Therapeutics, or Aurora Cannabis?
InvestorsObserver issues critical PriceWatch Alerts for AAL, CCL, PFE, APVO, and ACB. 
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.